CN103689742A - 一种高丽红参无花果饮料的制备方法 - Google Patents
一种高丽红参无花果饮料的制备方法 Download PDFInfo
- Publication number
- CN103689742A CN103689742A CN201410005540.9A CN201410005540A CN103689742A CN 103689742 A CN103689742 A CN 103689742A CN 201410005540 A CN201410005540 A CN 201410005540A CN 103689742 A CN103689742 A CN 103689742A
- Authority
- CN
- China
- Prior art keywords
- powder
- ginseng
- red ginseng
- korean
- filtrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 56
- 239000000706 filtrate Substances 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 238000003756 stirring Methods 0.000 claims abstract description 18
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- 235000002789 Panax ginseng Nutrition 0.000 claims description 47
- 235000002791 Panax Nutrition 0.000 claims description 18
- 241000208343 Panax Species 0.000 claims description 18
- 238000000638 solvent extraction Methods 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 13
- 241000186000 Bifidobacterium Species 0.000 claims description 12
- 244000025361 Ficus carica Species 0.000 claims description 9
- 235000008730 Ficus carica Nutrition 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 5
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 4
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract description 3
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 abstract description 2
- 238000012827 research and development Methods 0.000 abstract description 2
- 238000010025 steaming Methods 0.000 abstract description 2
- 238000002386 leaching Methods 0.000 abstract 3
- 235000007877 Diospyros australis Nutrition 0.000 abstract 2
- 240000002577 Prunus nigra Species 0.000 abstract 2
- 235000010875 Prunus nigra Nutrition 0.000 abstract 2
- 235000018288 Vitex doniana Nutrition 0.000 abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 238000009924 canning Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 230000001093 anti-cancer Effects 0.000 description 10
- 240000004371 Panax ginseng Species 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930192392 Mitomycin Natural products 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 235000011158 Prunus mume Nutrition 0.000 description 2
- 244000018795 Prunus mume Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 1
- STGNLGBPLOVYMA-MAZDBSFSSA-N (E)-but-2-enedioic acid Chemical compound OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O STGNLGBPLOVYMA-MAZDBSFSSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 1
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 240000001910 Momordica cochinchinensis Species 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 240000005049 Prunus salicina Species 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010062129 Tongue neoplasm Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- BHLWLVTYEDJFGZ-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1.O=CC1=CC=CC=C1 BHLWLVTYEDJFGZ-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- OVYQSRKFHNKIBM-UHFFFAOYSA-N butanedioic acid Chemical compound OC(=O)CCC(O)=O.OC(=O)CCC(O)=O OVYQSRKFHNKIBM-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 208000025085 carcinoma of parotid gland Diseases 0.000 description 1
- -1 carrotene Proteins 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- KYYWBEYKBLQSFW-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O KYYWBEYKBLQSFW-UHFFFAOYSA-N 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- NIFHFRBCEUSGEE-UHFFFAOYSA-N oxalic acid Chemical compound OC(=O)C(O)=O.OC(=O)C(O)=O NIFHFRBCEUSGEE-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 108010004621 phosphoketolase Proteins 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 201000006134 tongue cancer Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明所属保健食品研究开发技术领域。本发明涉及一种高丽红参无花果饮料的制备方法。将浸提罐中装入高丽红参5年根粉末、无花果粉末，乌梅粉末、大枣粉末；将β-环糊精溶于80℃蒸参水中，将此溶液注入浸提罐中与高丽红参5年根粉末、无花果粉末、乌梅粉末和大枣粉末混合，搅拌和浸提，过滤，得到滤液，重复提取残渣二次；将滤液合并，加红糖、食盐，搅拌，过滤，得到滤液，将滤液装罐或装瓶，灭菌即可。本发明产品具有强身健体的功能。
Description
技术领域
本发明所属保健食品研究开发技术领域。本发明涉及一种高丽红参无花果饮料的制备方法。本发明产品具有强身健体的功能。
背景技术
1高丽红参系由产自韩国的高丽鲜参经蒸、烘烤加工而成，在加工高丽红参过程中，有新的抗癌活性成分产生。高丽红参不凉也不热，属于温性；高丽参虽性温但补性强，益气助火。高丽参又分白参和红参，脾虚火旺者宜用白参，因“生用气凉，微苦补阴”;脾虚肺怯者宜用红参，“熟用气温，味甘补阳”。总体来说，高丽参更适合老年气虚症状明显的人服用，能强壮体质，增强免疫力。
高丽红参的功效：
（1）益智健脑：对记忆力减退和运动协调能力下降的人以及经常喝酒或接触带乙醇成分的食物、药物的人，高丽红参具有提高脑力工作能力、增强记忆力和改善脑缺血性障碍的功效
（2）镇痛：一些专家通过做传感神经细胞试验发现，高丽参对身体各种疼痛症状都有所帮助。
（3）防癌和抗癌：高丽红参的皂苷成分和非皂苷成分有抑制多种癌细胞的增殖活性，同时也可抑制癌细胞转移。另外，高丽红参与抗癌剂同服用，抗癌效果要好于单独用抗癌剂(丝裂霉素)。这是因为肿瘤化疗中癌细胞易形成耐受，高丽红参与抗癌剂同服用，增强对癌细胞的杀伤力、减轻抗癌剂的副作用。
（4）增强免疫力：高丽红参提取物可恢复因服用具有免疫毒性的抗癌剂(丝裂霉素)而下降的细胞性免疫反应，尤其***提取物可激活或增强细胞性免疫，及自然杀伤细胞的活性，对提高免疫力有很大的功效。
（5）控制糖尿病：高丽红参含有促进胰岛素分泌和类似胰岛素作用的物质，其中人参皂苷能改善高血糖，有效地控制糖尿病的发生。
（6）健肝：高丽参成分中有抗肝炎活性，具有解毒、保护肝脏及促进肝再生、恢复的作用。此外，高丽红参还有解酒、消除宿醉的作用。
（7）调节血压：高丽红参具有扩张血管作用，能改善血液循环，其中的皂苷成分通过促进血管内皮细胞释放一氧化氮，可达到降血压作用。
（8）抗疲劳及抗压：经研究发现，持续服用高丽红参可以提高运动能力和缓解疲劳，对促进运动员疲劳累积的恢复和预防运动性贫血有很大帮助;此外，高丽红参还可以增强对低温(5℃、O℃、-10℃)及高温(35℃)等不利环境的耐受力，通过对压力或环境变化进行精妙调节，提高抗压能力，维持机体稳定性。
（9）改善女性更年期障碍：据调查，有更年期障碍症状的女性在服用高丽红参后，有80%的人承认服用高丽红参后症状明显改善。专家称，这些女性如根据症状来调整用量，还可提高疗效。
（10）改善男性性功能障碍：高丽红参可防止因压力导致的男性性功能障碍。经临床试验，***障碍患者(90人)服用高丽红参后，在***程度、***及满意度等方面都有所改善。
（11）抗氧化及抗衰老：高丽红参具有抑制有害活性氧的增多和脂类过氧化的抗氧化效果。
2无花果无花果性味甘、平，无毒。含有果含糖类、枸橼酸、苹果酸、醋酸、酶等。
无花果的功效：
开胃，止泻痢，治五痔：为缓和滋养润肠药，有催乳作用，兼具驱虫、消炎、消肿之功。果枝和叶都含有消化酵素，可作辅助消化药用。
无花果利咽：无花果两枚，开水冲泡，代茶频饮;无花果鲜果晒干研末，吹咽喉部;无花果15克，水煎后加冰糖适量调服，代茶频饮之。
无花果抗癌：果实乳汁对肉瘤，乳瘤，腺癌，白血病，淋巴肉瘤均有抑制作用。临床用治各类恶性肿瘤，包括舌癌，肺癌，腮腺癌，胃癌，肝癌，结肠癌，肾癌等。食方：鲜无花果50克，瘦肉100克，水炖半小时，服汤吃肉。连服一段时间，不少于30天。也可用无花果15克，开水冲泡代茶，天天饮服。
无花果降糖：无花果水提取液，具有降低血糖作用。食方：无花果15克，宁夏枸杞子10克，加水煎沸。代茶饮，每日1剂，最后嚼服无花果及枸杞子。也可用无花果50克，苦瓜100克，均切成片状，加水煮汤，调味可饮食，连服7--10天。
无花果健胃：无花果酵素与胃液混合，有助消化，但宜生食。食欲欠佳者，每日可嚼服无花果，每次1枚，每日3次，以饭前1小时为宜。对习惯性便秘，痔疮出血，慢性胃炎等疾病，服之亦有效。
3乌梅8乌梅乌梅别名酸梅、黄仔、合汉梅、干枝梅，为蔷薇科落叶乔木植物梅Prunusmume的近成熟果实。果实含枸橼酸(citric acid），苹果酸(malic acid），草酸(oxalic acid），琥珀酸(succinic acid）和延胡索酸(fumaric acid）总酸量约4%-5.5%，以前两种有机酸的含量较多。还含5-羟甲基-2-糠醛(5-hydroxymethyl-2-furaldehyde），为无色油状物。所含挥发性成分，主要有苯甲醛(benzaldehyde)62.40%，4-松油烯醇(terpinen-4-ol)3.97%，苯甲醇（benzyl alcohol)3.97%和十六烷酸(hexadecanoic acid)4.55%。乌梅仁含苦杏仁苷(amygdalin）约0.5%，而梅仁含约4.3%。另有报道乌梅中还含苦味酸（picric acid）和超氧化物歧化酶(SOD）。具有保护肠胃、消除便秘、增进食欲、改善肝脏机能、防老化、清血、可软化血管，推迟血管硬化、孕妇止吐、解酒功能、增加能量、能预防疾病、防老抗衰及消除疲劳的功能。乌梅提取物也可作为天然防腐剂。
4大枣大枣又名红枣、干枣、枣子，起源于中国，在中国已有八千多年的种植历史，自古以来就被列为“五果”（栗、桃、李、杏、枣）之一。大枣富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分。其中维生素C的含量在果品中名列前茅，有维生素王之美称。
5蒸参水蒸参水是加工红参过程中的副产品，含有单体人参皂苷Rb1、Rb2、Rc、Rd、Re、Rf、Rg等，还含有人参多糖和微量挥发油等。
6双歧杆菌双歧杆菌Bifidobacterium是1899年由法国学者Tissier从母乳营养儿的粪便中分离出的一种厌氧的革兰氏阳性杆菌，末端常常分叉，故名双歧杆菌。双歧杆菌属革兰氏阳性、厌氧、不运动、无芽孢、形态多变的杆菌,其染色不规则,过氧化氢酶呈阴性。菌落光滑,凸圆边缘完整,乳脂呈白色,闪光并有柔软质地。葡萄糖代谢属异型发酵,具有磷酸转酮酶活性,可将2mol葡萄糖酵解为3mol乙酸和2mol乳酸。广泛存在于人和动物的肠道,反刍动物的瘤胃,以及人的齿缝中。其最适生存温度为37～42℃,最适pH值6.5～7.0。
双歧杆菌具有以下治疗效果：（1）维护肠道正常细菌菌群平衡，抑制病原菌的生长，防止便秘，下痢和胃肠障碍等；（2）抗肿瘤；（3）在肠道内合成维生素、氨基酸和提高机体对钙离子的吸收；（4）降低血液中胆固醇水平，防治高血压；（5）改善乳制品的耐乳糖性，提高消化率；(6)增强人体免疫机能，预防抗生素的副作用，抗衰老，延年益寿。
一参三果制备的高丽红参无花果饮料具有强身健体的功能。
发明内容
1、一种高丽红参无花果饮料的制备方法，特征在于其步骤如下：
（1）原辅料组成及配比为高丽红参5年根粉末0.1-1.5kg、无花果粉末0.2-3.0kg、乌梅粉末0.5-1.0kg、大枣粉末0.1-2.0kg、β-环糊精0.015-0.300kg、蒸参水0.6-12.0L、0.1-0.2%双歧杆菌、红糖0.05-1.00kg、食盐0.001-0.006kg；
（2）将浸提罐中装入高丽红参5年根粉末0.1-1.5kg、无花果粉末0.2-3.0kg、乌梅粉末0.5-1.0kg、大枣粉末0.1-2.0kg；
（3）将β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与高丽红参5年根粉末0.1-1.5kg、无花果粉末0.2-3.0kg、乌梅粉末0.5-1.0kg、大枣粉末0.1-2.0kg混合，搅拌和浸提3-4h，过滤，得到滤液和残渣；
（4）取β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与（3）中残渣混合，搅拌和浸提2-3h，过滤，得到滤液和残渣；
（5）取β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与（4）中残渣混合，搅拌和浸提1-2h，过滤，得到滤液和残渣；
（6）将（3）、（4）和（5）中滤液合并，加入0.1-0.2%双歧杆菌，在温度37-42℃进行24-48h发酵；
（7）将（6）中发酵液加入红糖0.05-1.00kg、食盐0.001-0.006kg，搅拌，过滤，得到滤液，将滤液装罐或装瓶，120-125℃，10-15分钟灭菌即可。
具体实施方式
本发明所述的涉及一种高丽红参无花果饮料的制备方法包括以下实施例，下面的实施例可进一步说明本发明，但不以任何方式限制本发明。
实施例1:
1、一种高丽红参无花果饮料的制备方法，特征在于其步骤如下：
（1）原辅料组成及配比为高丽红参5年根粉末0.1kg、无花果粉末0.2kg、乌梅粉末0.5kg、大枣粉末0.1kg、β-环糊精0.015kg、蒸参水0.6L、0.1%双歧杆菌、红糖0.05kg、食盐0.001kg；
（2）将浸提罐中装入高丽红参5年根粉末0.1kg、无花果粉末0.2kg、乌梅粉末0.5kg、大枣粉末0.1kg；
（3）将β-环糊精0.005kg溶于80℃蒸参水0.2L中，将此溶液注入浸提罐中与高丽红参5年根粉末0.1kg、无花果粉末0.2kg、乌梅粉末0.5kg、大枣粉末0.1kg混合，搅拌和浸提3h，过滤，得到滤液和残渣；
（4）取β-环糊精0.005kg溶于80℃蒸参水0.2L中，将此溶液注入浸提罐中与（3）中残渣混合，搅拌和浸提2h，过滤，得到滤液和残渣；
（5）取β-环糊精0.005kg溶于80℃蒸参水0.2L中，将此溶液注入浸提罐中与（4）中残渣混合，搅拌和浸提1h，过滤，得到滤液和残渣；
（6）将（3）、（4）和（5）中滤液合并，加入0.1%双歧杆菌，在温度37℃进行48h发酵；
（7）将（6）中发酵液加入红糖0.05kg、食盐0.001kg，搅拌，过滤，得到滤液，将滤液装罐或装瓶，120℃，15分钟灭菌即可。
实施例2:
1、一种高丽红参无花果饮料的制备方法，特征在于其步骤如下：
（1）原辅料组成及配比为高丽红参5年根粉末1.5kg、无花果粉末3.0kg、乌梅粉末1.0kg、大枣粉末2.0kg、β-环糊精0.300kg、蒸参水12.0L、0.2%双歧杆菌、红糖1.00kg、食盐0.006kg；
（2）将浸提罐中装入高丽红参5年根粉末1.5kg、无花果粉末3.0kg、乌梅粉末1.0kg、大枣粉末2.0kg；
（3）将β-环糊精0.100kg溶于80℃蒸参水4.0L中，将此溶液注入浸提罐中与高丽红参5年根粉末1.5kg、无花果粉末3.0kg、乌梅粉末1.0kg、大枣粉末2.0kg混合，搅拌和浸提4h，过滤，得到滤液和残渣；
（4）取β-环糊精0.100kg溶于80℃蒸参水4.0L中，将此溶液注入浸提罐中与（3）中残渣混合，搅拌和浸提3h，过滤，得到滤液和残渣；
（5）取β-环糊精0.100kg溶于80℃蒸参水4.0L中，将此溶液注入浸提罐中与（4）中残渣混合，搅拌和浸提2h，过滤，得到滤液和残渣；
（6）将（3）、（4）和（5）中滤液合并，加入0.2%双歧杆菌，在温度42℃进行24h发酵；
（7）将（6）中发酵液加入红糖1.00kg、食盐0.006kg，搅拌，过滤，得到滤液，将滤液装罐或装瓶，125℃，10分钟灭菌即可。
Claims (1)
1.一种高丽红参无花果饮料的制备方法，特征在于其步骤如下：
（1）原辅料组成及配比为高丽红参5年根粉末0.1-1.5kg、无花果粉末0.2-3.0kg、乌梅粉末0.5-1.0kg、大枣粉末0.1-2.0kg、β-环糊精0.015-0.300kg、蒸参水0.6-12.0L、0.1-0.2%双歧杆菌、红糖0.05-1.00kg、食盐0.001-0.006kg；
（2）将浸提罐中装入高丽红参5年根粉末0.1-1.5kg、无花果粉末0.2-3.0kg、乌梅粉末0.5-1.0kg、大枣粉末0.1-2.0kg；
（3）将β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与高丽红参5年根粉末0.1-1.5kg、无花果粉末0.2-3.0kg、乌梅粉末0.5-1.0kg、大枣粉末0.1-2.0kg混合，搅拌和浸提3-4h，过滤，得到滤液和残渣；
（4）取β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与（3）中残渣混合，搅拌和浸提2-3h，过滤，得到滤液和残渣；
（5）取β-环糊精0.005-0.100kg溶于80℃蒸参水0.2-4.0L中，将此溶液注入浸提罐中与（4）中残渣混合，搅拌和浸提1-2h，过滤，得到滤液和残渣；
（6）将（3）、（4）和（5）中滤液合并，加入0.1-0.2%双歧杆菌，在温度37-42℃进行24-48h发酵；
（7）将（6）中发酵液加入红糖0.05-1.00kg、食盐0.001-0.006kg，搅拌，过滤，得到滤液，将滤液装罐或装瓶，120-125℃，10-15分钟灭菌即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005540.9A CN103689742B (zh) | 2014-01-07 | 2014-01-07 | 一种高丽红参无花果饮料的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005540.9A CN103689742B (zh) | 2014-01-07 | 2014-01-07 | 一种高丽红参无花果饮料的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103689742A true CN103689742A (zh) | 2014-04-02 |
| CN103689742B CN103689742B (zh) | 2015-03-18 |
Family
ID=50351530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410005540.9A Active CN103689742B (zh) | 2014-01-07 | 2014-01-07 | 一种高丽红参无花果饮料的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103689742B (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104856037A (zh) * | 2015-06-05 | 2015-08-26 | 威海环翠楼红参科技有限公司 | 一种新资源食品高丽红参破壁粉制剂的制备方法 |
| CN105942068A (zh) * | 2016-05-28 | 2016-09-21 | 环翠楼红参生物科技股份有限公司 | 一种高丽红参汤的制备方法 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1907057A (zh) * | 2006-07-31 | 2007-02-07 | 冷跃鹃 | 增强免疫力的参茶饮料及其制作 |
| CN101411496A (zh) * | 2008-11-24 | 2009-04-22 | 朱立良 | 生态功能饮料 |
| CN101804086A (zh) * | 2010-04-21 | 2010-08-18 | 许兰 | 发酵红参制品的制备方法 |
| CN102318868A (zh) * | 2011-08-26 | 2012-01-18 | 吉林紫鑫药业股份有限公司 | 人参枸杞苹果饮料及其生产工艺 |
| CN102349675A (zh) * | 2011-09-30 | 2012-02-15 | 金道山 | 一种红参饮料及其制作方法 |
| CN102687889A (zh) * | 2012-05-30 | 2012-09-26 | 康美药业股份有限公司 | 一种植物饮料及其制备方法和应用 |
| CN102687821A (zh) * | 2012-05-04 | 2012-09-26 | 长春中医药大学 | 人参总皂苷为添加剂的系列运动功能饮料的制备方法 |
| CN103127202A (zh) * | 2011-11-30 | 2013-06-05 | 韩国食品硏究院 | 利用红参的红景天发酵物的制造方法及含有该发酵物的改善疲劳和提高运动能力的组合物 |
-
2014
- 2014-01-07 CN CN201410005540.9A patent/CN103689742B/zh active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1907057A (zh) * | 2006-07-31 | 2007-02-07 | 冷跃鹃 | 增强免疫力的参茶饮料及其制作 |
| CN101411496A (zh) * | 2008-11-24 | 2009-04-22 | 朱立良 | 生态功能饮料 |
| CN101804086A (zh) * | 2010-04-21 | 2010-08-18 | 许兰 | 发酵红参制品的制备方法 |
| CN102318868A (zh) * | 2011-08-26 | 2012-01-18 | 吉林紫鑫药业股份有限公司 | 人参枸杞苹果饮料及其生产工艺 |
| CN102349675A (zh) * | 2011-09-30 | 2012-02-15 | 金道山 | 一种红参饮料及其制作方法 |
| CN103127202A (zh) * | 2011-11-30 | 2013-06-05 | 韩国食品硏究院 | 利用红参的红景天发酵物的制造方法及含有该发酵物的改善疲劳和提高运动能力的组合物 |
| CN102687821A (zh) * | 2012-05-04 | 2012-09-26 | 长春中医药大学 | 人参总皂苷为添加剂的系列运动功能饮料的制备方法 |
| CN102687889A (zh) * | 2012-05-30 | 2012-09-26 | 康美药业股份有限公司 | 一种植物饮料及其制备方法和应用 |
Non-Patent Citations (2)
| Title |
|---|
| 徐忠等: "《功能性变性淀粉》", 30 April 2010 * |
| 马超婕等: "红参五加皮苹果汁复合饮料的研究", 《农业科技与装备》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104856037A (zh) * | 2015-06-05 | 2015-08-26 | 威海环翠楼红参科技有限公司 | 一种新资源食品高丽红参破壁粉制剂的制备方法 |
| CN105942068A (zh) * | 2016-05-28 | 2016-09-21 | 环翠楼红参生物科技股份有限公司 | 一种高丽红参汤的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103689742B (zh) | 2015-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102100279B (zh) | 灵芝咖啡饮料及其制作方法 | |
| CN101904375B (zh) | 一种女性保健养生饮品 | |
| CN103725572B (zh) | 一种高丽红参酒的制备方法 | |
| CN103609992B (zh) | 一种高丽红参膏的制备方法 | |
| CN103125710B (zh) | 一种女士用八珍茶 | |
| CN104171131A (zh) | 铁皮石斛茉莉花茶饮料及其制备方法 | |
| CN103689743B (zh) | 一种高丽红参桑椹饮料的制备方法 | |
| CN103749827B (zh) | 一种高丽红参无花果茶的制备方法 | |
| CN103695274B (zh) | 一种高丽参酒的制备方法 | |
| CN103695275B (zh) | 一种双参酒的制备方法 | |
| CN104109609A (zh) | 糯米酒荞麦果汁饮料及其制备方法 | |
| CN104770714A (zh) | 一种西洋参蜜片的加工工艺 | |
| CN103725467B (zh) | 一种高丽参红葡萄酒的制备方法 | |
| CN104187714B (zh) | 一种高丽红参膳食纤维膨化粉的制备方法 | |
| CN103704712B (zh) | 一种高丽红参含片的制备方法 | |
| CN103689742B (zh) | 一种高丽红参无花果饮料的制备方法 | |
| CN103704458B (zh) | 一种高丽参蜜片的加工工艺 | |
| CN103564572B (zh) | 一种高丽红参汤的制备方法 | |
| CN103750425B (zh) | 一种高丽红参罗汉果汤的制备方法 | |
| CN103689602B (zh) | 一种高丽红参口服液的制备方法 | |
| CN105146392A (zh) | 一种营养奶昔粉及其制备方法 | |
| CN104770787A (zh) | 一种西洋红参沙棘饮料的制备方法 | |
| CN104397822A (zh) | 一种灵芝固体饮品及其制备方法 | |
| CN103704840B (zh) | 一种高丽红参青果饮料的制备方法 | |
| CN103719499A (zh) | 一种高丽红参茶的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 264211 Weihai economic and Technological Development Zone, Lingang Road, Shandong, No. 58 Patentee after: HUANCUILOU RED GINSENG BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 264211 Weihai economic and Technological Development Zone, Lingang Road, Shandong, No. 58 Patentee before: WEIHAI HUANCUILOU RED GINSENG TECHNOLOGY Co.,Ltd. |
|
| PP01 | Preservation of patent right |
Effective date of registration: 20190905 Granted publication date: 20150318 |
|
| PP01 | Preservation of patent right | ||
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20210905 Granted publication date: 20150318 |
|
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 264200 No. 58, Taibei Road, Lingang Economic and Technological Development Zone, Weihai City, Shandong Province Patentee after: Shenyuanzhuang Biotechnology Co.,Ltd. Address before: No.58, Taibei Road, Lingang Economic and Technological Development Zone, Weihai City, Shandong Province Patentee before: HUANCUILOU RED GINSENG BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20211025 Granted publication date: 20150318 |
|
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20231025 Granted publication date: 20150318 |